Intervention

Diamyd

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials4

Recruiting0

Common conditions16

Lead sponsors shown3

Clinical trials

4 shown

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 DiabetesNCT05683990 · 2024-07-09

ACTIVE_NOT_RECRUITING

Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 DiabetesNCT03345004 · 2017-12-20

COMPLETED

Diabetes Prevention - Immune ToleranceNCT01122446 · 2009-04-01

COMPLETED

Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesNCT00837759 · 2009-02-01

TERMINATED

Common conditions

Autoimmune Diabetes2 Autoimmune Diseases2 Diabetes Mellitus, Type 12 Diabetes Mellitus1 Diabetes Mellitus Type 11 Endocrine System Diseases1 Glucose Metabolism Disorders1 Immune System Diseases1 Insulin Dependent Diabetes1 Juvenile Diabetes1 Metabolic Disease1 Physiological Effects of Drugs1 Prediabetes1 Prevention1 Type 1 Diabetes1 Vitamin D1

Leading sponsors

Diamyd Medical AB 2 Lund University 1 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

TERMINATED1

Phase mix

PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.